Biogen chairman Papadopoulos, who saw company through highs and lows, to retire
Biogen chairman Stelios Papadopoulos will step down later this year, ending a long-running tenure that culminated with one of biotech’s more volatile rides.
Papadopoulos — who has been Biogen’s chairman since 2014 — will leave his post before the end of the year, new CEO Chris Viehbacher said Wednesday, according to a spokesman for the company. The company hasn’t put out an official statement or regulatory filing, hasn’t said when the retirement will happen, and hasn’t named a replacement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.